Normal view MARC view ISBD view

Development and Characterization of Capsule Dosage Form of Gamma Oryzanol To Improve Bioavailability

By:

Material type: Text

Subject(s):

DDC classification:

Online resources:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode	Item holds
Dissertation	NIMA Knowledge Centre	Reference	615.19 BHO (Browse shelf(Opens below))	Not For Loan		PDR00711
CD/DVD	NIMA Knowledge Centre	Reference	615.19 BHO (Browse shelf(Opens below))	Not For Loan		PDR00711-1

Total holds: 0

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available			Next
Previous	615.19 BHE Osmotic Drug Delivery System	615.19 BHI Formulation And Development Of Reconstittutable oral Suspension of Anti Asthmatic Drug	615.19 BHI Formulation And Development Of Reconstittutable oral Suspension of Anti Asthmatic Drug	615.19 BHO Development and Characterization of Capsule Dosage Form of Gamma Oryzanol To Improve Bioavailability	615.19 BHO Development and Characterization of Capsule Dosage Form of Gamma Oryzanol To Improve Bioavailability	615.19 BIO Biodrug Delivery Systems:Fundamentals, Applications and Clinical Development	615.19 BIO Biological Drug Products: Development and Strategies	Next

Guided by Dr. Shital Butani

There are no comments on this title.

to post a comment.